SAMSONITE (01910) spent 4.9977 million Hong Kong dollars on January 6th to repurchase 22.83 thousand shares.

07/01/2025

GMT Eight

SAMSONITE (01910) announced that the company will spend 4.9977 million Hong Kong dollars to repurchase 22.83 million shares on January 6, 2025, at a repurchase price of 21.7-22.15 Hong Kong dollars per share.

Jiangsu Hengrui Pharmaceuticals (600276.SH) has submitted an application to the Hong Kong Stock Exchange for the issuance and listing of H shares.

Haitong: Continues to be optimistic about investment opportunities in AI applications.

Contact: contact@gmteight.com

SAMSONITE (01910) spent 4.9977 million Hong Kong dollars on January 6th to repurchase 22.83 thousand shares.

RECOMMEND

SSY GROUP (02005) has obtained the drug production registration approval from the National Medical Products Administration for fumaric acid foscarnet tablets (20mg and 10mg).

SANAI HEALTH GP (01889): The hearing to confirm the proposed reduction of capital was held in court on January 7th.

BEIGENE (06160) issued 542,900 shares of common stock through the exercise of stock options.